Qingfeng Zhu

14PUBLICATIONS
183CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyPredictive and prognostic markersSolid tumoursHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.

|Feb 24, 2026
iCLAP: an innovative method for integrable co-detection of low-abundance antigens with high-plex immunostaining.

Fan Wu, Shuyuan Zheng, Yani Chen

|Sep 24, 2025
Spatial profiling of human pancreatic ductal adenocarcinoma reveals molecular alterations associated with venous invasion.

Alexander T F Bell, Peter Chianchiano, Katsuya Hirose

|Aug 15, 2025
Neoadjuvant Immunotherapy Promotes the Formation of Mature Tertiary Lymphoid Structures in a Remodeled Pancreatic Tumor Microenvironment.

Dimitrios N Sidiropoulos, Sarah M Shin, Meredith Wetzel

|May 19, 2025
Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.

Eric S Christenson, Won Jin Ho, Daniel Shu

|Oct 25, 2024
Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma.

Daniel H Shu, Won Jin Ho, Luciane T Kagohara

Pageof 3

Frequent Collaborators

11 joint publications

Elizabeth M Jaffee

8 joint publications

Robert Anders

6 joint publications

Won Jin Ho

5 joint publications

Mark Yarchoan